BioXcel Therapeutics Inc (FRA:BX2)
€ 1.892 0.006 (0.32%) Market Cap: 72.49 Mil Enterprise Value: 98.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

Q1 2022 BioXcel Therapeutics Inc Earnings Call Transcript

May 09, 2022 / 12:30PM GMT
Release Date Price: €11.64 (-8.78%)
Operator

Good morning, and welcome to the BioXcel Therapeutics' First Quarter 2022 Financial Results Conference Call. At this (Operator Instructions).

Just to remind everyone, certain matters discussed in today's conference call and/or answers that may be given to questions asked are forward-looking statements subject to risks and uncertainties related to future events and/or the future financial performance of the company. Actual results could differ materially from those anticipated in these forward-looking statements.

Risk factors that may affect results are detailed in the company's most recent public filings with the U.S. Securities and Exchange Commission, including Bio's annual report on Form 10-K for the year ended December 31, 2021, which can be found at www.bioxceltherapeutics.com or on www.sec.gov, which will be updated in its quarterly report on Form 10-Q for the quarter ended March 31, 2022.

As a reminder, today's conference is being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot